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Abstract
Background: Previous studies have demonstrated that knockout or inhibition of Platelet/Endothelial Cell Adhesion
Molecule (PECAM, CD31) in a number of murine strains results in impaired inflammatory responses, but that no such
phenotype is seen in the C57BL/6 (B6) murine background.
Methodology/Principal Findings: We have undertaken a quantitative trait locus (QTL) mapping effort between FVB/n (FVB)
and B6 mice deficient for PECAM to identify the gene or genes responsible for this unique feature of B6 mice. We have
identified a locus on murine chromosome 2 at approximately 35.8 Mb that is strongly associated (LOD score=9.0) with
inflammatory responses in the absence of PECAM.
Conclusions/Significance: These data potentiate further study of the diapedesis machinery, as well as potential
identification of new components of this machinery. As such, this study is an important step to better understanding the
processes of inflammation.
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Introduction
Inflammation necessitates that leukocytes leave the blood stream
where they circulate and enter into tissue to engage in effector
functions. A well developed series of steps is involved regulating the
exit of leukocytes from the blood stream across the endothelial
barrier,a processreferred toasleukocytetransendothelialmigration
(TEM) [1,2]. The committed step of this process is referred to as
diapedesis, the step where the leukocyte actually squeezes between
two endothelial cells. It has been shown that the Platelet/
Endothelial Cell Adhesion Molecule (PECAM, CD31) is integral
to diapedesis. When the PECAM knockout mouse was first made,
however, no apparent blockade of leukocyte TEM was observed in
several in vivo models [3]. This early model was developed in a
hybrid of 129/J and C57BL/6 (B6) mice, and was further studied in
mice backcrossed extensively onto the B6 background. While a
delay was observed in the time it took leukocytes to cross the
basement membrane, and a number of other subtle defects have
been described in the literature, the expected blockade of diapedesis
was not seen [3,4,5,6,7,8,9,10,11,12,13].
Subsequent studies observed that transgenic FVB/n (FVB) mice
constitutively expressing moderate levels of a soluble ‘‘decoy’’
PECAM-Fc chimera in their circulation did manifest a blockade in
TEM of monocytes and neutrophils [14]. Studies were undertaken
that established that soluble PECAM-Fc chimeras and antibodies
against PECAM could block normal TEM of monocytes and
neutrophils in live mice for all strains tested except the B6 strain [15].
When the PECAM knockout was backcrossed into the FVB
background, a blockade in TEM was, in fact, observed [15]. These
data suggested an apparently unique ability of the B6 mice to
disregard loss or functional blockade of PECAM with respect to
TEM.
Given the inbred nature of laboratory mouse strains, it stands to
reason that a unique genetic element (or elements) in the B6 strain
is responsible for the observed phenomenon of PECAM-
independent TEM. As identification of such genetic elements
could reveal genes encoding for previously unidentified compo-
nents of the diapedesis machinery, and thus provide insights into
the exact mechanisms of this machinery, we undertook an effort to
map these genetic differences.
The technique of quantitative trait locus (QTL) mapping is a
powerful form of genetic linage mapping that can be used to dissect
such phenotypes where a quantitative difference exists between
genetically inbred mouse strains [16]. This particular technique
relies on comparing the quantitative phenotypic results for a
number of mice resulting from the breeding of two different mouse
strains with distinct quantitative differences in a given phenotype
(e.g. height, weight, serum cholesterol values, etc.). For each mouse
in the offspring, typically of the F2 (second filial, i.e. offspring of the
first filial generation, which are mice generated by crossing the two
parental strains) or B2 (backcross; offspring of mating mice from the
first filial generation to mice from one parental strain) generation, a
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values are compared to the genotype of specific markers throughout
the offspring’s genomes that are known to be different between the
parental strains, and thus indicating the parental strain of origin for
each marker region, and thus also each gene linked to that region,
throughout those genomes. Typically, due to the development of
appropriate high-throughput assays, the variations mapped in such
efforts are either microsatellite repeat markers, where variation is
determined by different lengths of the microsatellite between parent
strains assayed via multiplex PCR, or single-nucleotide polymor-
phisms (SNPs), where the parent strains are known to have different
alleles for the given SNP assayed through microarray technologies.
Computer software is then utilized to perform a regression analysis
at each possible locus compared to the quantitative phenotype
results, often taking into account linkage of nearby loci, and
returning a likelihood of each given locus being associated with the
phenotype of interest.
Utilizing a previously described microsatellite panel known to
distinguish between genetic elements in FVB and B6 mice [17], as
well as a well-characterized SNP database capable of similar
differentiation between the FVB and B6 murine strains [18], we
undertook a QTL mapping strategy to identify the locus or loci of
genetic trait or traits responsible for the apparently unique ability
of leukocytes from B6 mice, as compared primarily to those from
FVB mice, to transmigrate even in the absence of PECAM.
Materials and Methods
Mice
All animal procedures were reviewed and approved by the
Institutional Use and Care of Animals Committee (IACUC) of
Weill Cornell Medical College. C57BL/6 Pecam
2/2 and FVB/n
Pecam
2/2 mice were developed as previously described with at
least nine backcrosses into each respective strain [3,15]. Wild-type
C57BL/6J (‘‘B6’’), C57BL/10J (‘‘B10’’), DBA/2J (‘‘D2’’), FVB/
nChr (‘‘FVB’’), Balb/cChr (‘‘Balb/c’’) mice were purchased from
either The Jackson Laboratory (Bar Harbor, ME), or Charles
River Laboratories (Wilmington, MA), as indicated by the strain
name suffix. All mice were maintained and bred at the Weill
Cornell Medical College Research Animal Resource Center.
Thioglycollate Peritonitis
Thioglycollate peritonitis (TGP) was performed as described
previously [3,14,15,19] and in accordance with the policies set
forth by the Institutional Animal Care and Use Committee
(IACUC) of Weill Cornell Medical College. Wild-type mice were
injected via tail vein with 100 mL of either PBS or a solution of
anti-PECAM (Armenian hamster anti-mouse, clone 2H8, [20]) or
soluble PECAM-Fc chimera [14,15] in PBS (both blocking
reagents at 1 mg/mL); prior studies utilizing isotype control
antibodies revealed no difference from PBS-only injection [20,21].
One hour later (or at the start of the experiment, in the case of
knockout mice), mice were injected intraperitoneally with 1 mL of
4% Difco thioglycollate broth (Becton-Dickinson, Franklin Lakes,
NJ). After 18 hr, mice were euthanized and a peritoneal lavage
was performed using 5 mL of HBSS containing 10 mM ethylene
diamine tetraacetic acid (EDTA). Lavage material was assayed
manually for total (hemacytometer) and differential cell counts
(cytospins stained with modified Wright-Giemsa stain, Protocol
Hema3, Fisher Diagnostics, Middletown, VA). Murine blood was
also collected to ensure comparable peripheral blood counts
between groups. Data were tabulated and analyzed using
Microsoft Excel (Microsoft Corporation, Redmond, WA) and
the R statistical software package (http://cran.r-project.org/).
Low-density QTL mapping and analysis
Kidneys from mice used in the thioglycollate peritonitis were
removed immediately following peritoneal lavage and stored at
280uC. From these kidneys, genomic DNA was extracted using
the Qiagen DNeasy Blood and Tissue Kit (Qiagen Inc., Valencia,
CA) as described in the manufacturer’s protocol. Genomic DNA
was analyzed for Whitehead Institute microsatellite repeat
polymorphisms using the protocol described by Teupser et al.
[17] to distinguish between FVB and B6 mice. Assays were
performed by the Rockefeller University Genomics Resource
Center, New York, NY, using multiplex PCR with fluorescent dye-
coupled primers and laser scanning capillary gel electrophoresis.
Resulting genotype data were tabulated in Microsoft Excel and
then analyzed using the R/qtl package [22].
Medium-density QTL mapping and analysis
DNA from the same mice was subjected to additional
genotyping using the Illumina Mouse MD (Medium Density)
Linkage Panel (Illumina, Inc., San Diego, CA) [18], performed by
the Rockefeller University Genomics Resource Center. Resulting
data were analyzed manually within the region of interest, and
genome-wide using the R/qtl software package.
Gene database searches
Genes in the area(s) of interest were identified using databases at
theNCBI(http://www.ncbi.nlm.nih.gov/),UCSCGenomeBrowser
(http://genome.ucsc.edu/), Ensembl (http://www.ensembl.org/),
and Mouse Genome Informatics (MGI, http://www.informatics.
jax.org/). Map positions are given in NCBI sequence positions.
Results
Pecam
2/2 mouse breeding
SNP genotyping, using the Illumina medium density array, of
the parental B6 and FVB PECAM-deficient mice revealed the B6
mice to be 98.2% backcrossed and the FVB mice to be 99.7%
backcrossed relative to standard stock mice of the respective strain.
These values are within conventional standards for use of
knockout mice.
Response to inflammatory challenge
F1 mice generated from crosses of B6 and FVB PECAM-
deficient mice showed a phenotype most consistent with the B6
parents, i.e. they tended to display ongoing robust inflammatory
responses to thioglycollate despite lack of PECAM (Figures 1 and
2; Supplemental Table S1). There was an equivalent number of
male and female offspring in the F1 generation with no significant
difference between them in terms of thioglycollate response (data
not shown). There was a difference observed, however, between
the mice generated from B6 mothers and FVB fathers (BxF) as
compared to those from FVB mothers and B6 fathers (FxB),
suggesting an imprinted trait modifying the F1 phenotypes. Both
groups varied significantly from FVB parents and not from B6
parents, suggesting a dominantly inherited trait, but those with B6
mothers showed more robust responses than those mice with FVB
mothers. At this time, we have not performed any studies to
attempt to identify the imprinted gene or genes involved in this
phenomenon.
F2 mice generated from the F1 mice showed a distribution of
inflammatory responses extending between the two parental
strains (Figures 1 and 2). The mean response varied from all
other groups except the F1 FxB mice (Supplemental Table S1).
There was no significant correlation between the response to
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(Supplemental Figure S2), or age (Supplemental Figure S3) of
these mice. Analysis of the distribution of the inflammatory
phenotypes in the F2 mice was conducted using statistical
modeling (Supplemental Figure S4). These models are consistent
with a single-gene Mendelian model having a classic 1:3
distribution, and thus these data are consistent with a single gene
autosomal dominant Mendelian trait.
Low-density QTL mapping
To identify the gene responsible for the phenotypes we
observed, we undertook QTL mapping in the F2 mice. An initial
mapping study using approximately 150 markers distributed
throughout the murine genome identified a single significant locus
on the proximal end of chromosome 2 (Figure 3A; peak at d2mit7,
38.2 Mb). Statistical significance for such loci is traditionally
measured by a logarithm of odds, or LOD, score, which is roughly
equivalent to negative logarithm of the p-value for the significance
of association; i.e. a locus with LOD=4 is 10-times more strongly
associated to the phenotype of interest than is one with LOD=3.
Statistical significance is typically reached at a value of LOD=3.0;
this locus had a LOD score of 7.5, suggesting very strong
association between the locus and the phenotype of interest.
Several of the genes near this locus are identified in the
schematic map in Figure 3B. These genes were identified using the
Mouse Genomics Informatics site’s search engine to identify genes
associated with immunologic or hematologic function, including
the Abl1 (c-abl) oncogene, Traf1 (TNF-receptor associated factor
1), Eng (endoglin), the prostaglandin synthases Ptgs1/COX-1,
Ptges1, and Ptges2, and the hemolytic complement gene Hc (C5).
Medium-density QTL mapping
We then undertook a medium-density mapping study using the
Illumina Medium Density Mouse Linkage Analysis system [18].
We chose to map only those mice with known crossover events in
the region of interest, and we successfully obtained medium-
density genotypes from fourteen of these mice, as well as one
mouse from each parental strain. This medium-density mapping
study supported the association of the identified QTL peak with
the phenotype of interest, and furthermore strengthened the LOD
score at the QTL peak (Figure 4A, LOD=9.0) and narrowed the
region of interest (Figure 4B, peak 35.8 Mb).
Analysis of Hc as a candidate gene
Looking at the literature for published QTLs in the region near
murine Chr 2, 35.8 Mb, a majority of the immunological
phenotypes are associated with the hemolytic complement gene,
Hc, a.k.a. complement component C5 [23,24,25,26,27,28,29,30].
Since this gene is known to be a major variant in inbred mouse
populations [31,32,33,34,35], with some strains carrying a
premature stop codon and thus effectively being Hc-null, and
further recognizing B6 mice as Hc-positive and FVB as Hc-null, we
Figure 1. Thioglycollate peritonitis in three generations of PECAM-deficient mice. Thioglycollate peritonitis (TGP) was performed as
described in Materials and Methods. All bars show mice that received 1 mL of 4% thioglycollate broth intraperitoneally. The mean inflammatory score
and standard error of that mean is shown for each generation of knockout mice generated during the crossing of FVB and B6 PECAM-deficient mice.
Data include 14 FVB mice, 14 B6 mice, 6 F1 BxF mice, 7 F1 FxB mice, and 110 F2 mice. *: groups vary from each other significantly; **: group varies from
several other groups significantly; ***: group varies from all other groups significantly; detailed statistical comparisons are reported in Supplemental
Table S1.
doi:10.1371/journal.pone.0004316.g001
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independent inflammatory phenotype in correlation with their Hc
status. In conjunction with previously published data [15], we
found that the thioglycollate peritonitis results were independent of
Hc-status; only B6 mice demonstrate PECAM-independent
thioglycollate peritonitis (Figure 5). It is notable that while the
blockade in Balb/c and DBA/2 mice does not reach statistical
significance, the B10 mouse strain does clearly show a blockade,
and yet is Hc-positive.
Discussion
We have identified a single locus, at 35.8 Mb on murine
chromosome 2, associated with PECAM-independent inflamma-
tion in the thioglycollate peritonitis (TGP) model. This trait is
inherited in an autosomal dominant Mendelian manner, although
other traits, particularly an imprinted trait observed in the F1 mice,
do modify the observed phenotypes. We suggest a name of Pitgp
for this locus, short for PECAM-independent thioglycollate
peritonitis.
While a number of existing QTLs are near this same locus and
associated with the hemolytic complement component C5 Hc
gene, it appears that the classic variation in this gene, a premature
stop codon, does not account for the variation seen, as only B6
mice show PECAM-independent TGP, while other Hc-positive
strains do not.
The other gene candidates at the QTL locus primarily include
COX-1 (Ptgs1), and the PGE2-synthases 1 and 2 (Ptges and Ptges2).
Prostaglandins, especially prostaglandin E2, are known to be
potent mediators of inflammatory responses in vivo, and it would
seem reasonable that the prostaglandin synthetic enzymes may
play a role in regulating TEM. Unfortunately, due to the complex
biology of prostaglandins [36,37,38,39,40,41,42], we have not yet
been able to evaluate these candidates functionally in vivo.
Knockout mice are available for the genes in question [43,44],
but many generations of backcrossing or, to avoid carryover of
Figure 2. Histograms showing distributions of individuals within three generations of PECAM-deficient mice. The histograms each
show the number of mice having inflammation scores within a given range (cell increment 2610
5 PMN per mL). Overlays allow for visualization of the
degree of overlap between the respective populations.
doi:10.1371/journal.pone.0004316.g002
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will be required before we can evaluate the function of these genes
in the context of this study. Further genetic dissection of this locus
is limited by the power of linkage analysis and the mosaic structure
of the murine genome, leading to a high degree of linkage
disequilibrium in the region of interest [45]. While the
development of congenic mice for these loci and appropriate
strains of candidate gene knockouts are under development, it will
be some time before the definitive gene or genes responsible for
the phenotype associated with Pitgp1 locus is/are identified.
It is likely that the Pitgp
B6 allele is a gain-of-function mutation
that confers some novel adhesion and/or signaling pathway onto
B6 mice not found in other strains. However, it should be noted
that in no strain of mouse does PECAM blockade or genetic
deletion lead to overt immunosuppression. As such, there must be
competent immune mechanisms in all mouse strains even in the
absence of PECAM. It becomes necessary, therefore, to ask which
circumstances require the use of PECAM in TEM and which are
independent. A number of other inflammatory models have been
examined using PECAM blockade or knockout, some being
PECAM-dependent while others are PECAM-independent. Many
of the situations where TEM is PECAM-independent are
conditions where direct activation of the leukocyte may have
taken place [46]. It is possible, therefore, that factors released by
activated leukocytes obviate the need for PECAM-PECAM
engagement, and the gain-of-function mutation mapped in this
study causes dysregulated release of such factors.
Regardless of the mechanism at work, the identification of this
locus allows for breeding of congenic mice for the Pitgp allele onto
various genetic backgrounds. Using these mice, we hope to explore
the full range of inflammatory stimuli for which this QTL explains
interstrain differences. In combination with the data showing
which events are PECAM-dependent, it becomes possible to begin
building a more complete picture of the mechanisms leading to
TEM in any given setting. Additionally, once we have the murine
tools to follow the effect of both the PECAM and Pitgp loci, we
may be able to identify new loci that play a role in other strains or
other inflammatory settings, and thus possibly identify yet more
signals that play a role in the control of TEM.
Supporting Information
Table S1 P-values from pairwise statistical comparisons of the
data presented in Figure 1. Significant values are indicated in bold.
Found at: doi:10.1371/journal.pone.0004316.s001 (0.02 MB
XLS)
Figure S1 Histograms comparing the distribution of female and
male mice in the F2 generation. The histograms each show the
number of mice of the given gender having inflammation scores
within a given range (cell increment 2610
5 PMN per mL).
Statistical comparison of the two groups yields a Welch two-
sample t-test p-value of 0.296 and a Mann-Whitney (Wilcoxon) u-
test p-value of 0.283.
Found at: doi:10.1371/journal.pone.0004316.s002 (6.63 MB TIF)
Figure S2 Histograms comparing the distribution of black,
brown, and white mice in the F2 generation. The histograms each
show the number of mice of the given coat color having
inflammation scores within a given range (cell increment 2610
5
PMN per mL). Statistical comparison of the black and brown
Figure 3. Low-density QTL mapping results. The low-density microsatellite mapping study revealed a single locus (panel A) breaking genome-
wide association cutoffs. Panel B shows a close-up view of that locus, at 38.2 Mb (NCBI map coordinates), indicated by an arrow, as well as a number
of nearby genes identified in databases as relevant to inflammation, immunity, or hematologic function.
doi:10.1371/journal.pone.0004316.g003
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Mann-Whitney (Wilcoxon) u-test p-value of 0.924. Statistical
comparison of the black and white groups yields a Welch two-
sample t-test p-value of 0.515 and a Mann-Whitney (Wilcoxon) u-
test p-value of 0.386. Statistical comparison of the brown and
white groups yields a Welch two-sample t-test p-value of 0.225 and
a Mann-Whitney (Wilcoxon) u-test p-value of 0.204.
Found at: doi:10.1371/journal.pone.0004316.s003 (8.49 MB TIF)
Figure S3 Scatterplot comparing the inflammation scores mice
in the F2 generation to the age of the mouse at the time of the
experiment. Each circle on the plot represents a single mouse. The
dashed line represents a least-squares regression fit; R
2 val-
ue=0.002, p-value 0.398.
Found at: doi:10.1371/journal.pone.0004316.s004 (10.74 MB
TIF)
Figure S4 Statistical modelling of the F2 population. Statistical
models representing the mathematical distribution of the F2 mice
were built in the R statistical package to evaluate for the number of
subpopulation that could be identified. Non-parametric densities
of the various distributions were estimated using three different
functions, density, bkde (at two different kernel values), and hist.
The four resulting probability estimates were modeled with the
non-linear modeling function, nls, using varying numbers of
normally distributed subpopulations. Coefficients were tested
against expectations using chi-square and Fisher’s exact tests
(both tests designed to compare expected and observed count
data), and model errors were the residual summed square values
(an algorithm that computes the difference between the model and
the actual data at hundreds of data points, and returns an unsigned
sum of the differences). A representative non-parametric density
model is shown overlaying the parental, F1, and F2 populations in
panels A and B. Panel C shows the resulting bimodal and
unimodal mathematical models, demonstrating that a bimodal
distribution, i.e. a mathematical model composed of two
overlapping but distinct subpopulations, is more robust than a
unimodal model, i.e. a mathematical model in which the mice all
appear to be part of a single large population. Trimodal models,
not shown, were only subtle variations on the bimodal models,
rather than a distinctly different distribution. Tetramodal models
Figure 4. Medium-density QTL mapping results. Using a proprietary allele-specific primer extension based assay, the Illumina GoldenGate
technology, the QTL peak was narrowed to a point at 35.8 Mb (panel A). Near this well-defined peak are four genes of particular interest (panel B,
colored circles at top of graph, from left to right): Ptges, coding for mPGES-1 (prostaglandin E2 synthase 1, green); Ptges2, coding for PGES-2
(prostaglandin E2 synthase 2, blue); Hc, coding for hemolytic complement component C5 (black); and Ptgs1, coding for the protein commonly known
as COX-1 (red); these four genes are also indicated in the lower row of genes identified in Figure 3B. The LOD score=3.0 threshhold for significance is
inidcated by a horizontal grey line in both panels.
doi:10.1371/journal.pone.0004316.g004
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single-gene Mendelian model of 1:3 distribution. Imposing an
exact 1:3 ratio on the models results in errors very similar to the
unconstrained models. In total, these data are consistent with a
single gene autosomal dominant Mendelian trait.
Found at: doi:10.1371/journal.pone.0004316.s005 (3.38 MB TIF)
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